259 related articles for article (PubMed ID: 30449328)
1. Does memantine improve memory in subjects with focal-onset epilepsy and memory dysfunction? A randomized, double-blind, placebo-controlled trial.
Leeman-Markowski BA; Meador KJ; Moo LR; Cole AJ; Hoch DB; Garcia E; Schachter SC
Epilepsy Behav; 2018 Nov; 88():315-324. PubMed ID: 30449328
[TBL] [Abstract][Full Text] [Related]
2. Randomized, placebo-controlled, crossover trial of memantine for cognitive changes with corticosteroid therapy.
Brown ES; Vazquez M; Nakamura A
Biol Psychiatry; 2008 Oct; 64(8):727-729. PubMed ID: 18582848
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Peyro Saint Paul L; Creveuil C; Heinzlef O; De Seze J; Vermersch P; Castelnovo G; Cabre P; Debouverie M; Brochet B; Dupuy B; Lebiez P; Sartori É; Clavelou P; Brassat D; Lebrun-Frenay C; Daplaud D; Pelletier J; Coman I; Hautecoeur P; Tourbah A; Defer G
J Neurol Sci; 2016 Apr; 363():69-76. PubMed ID: 27000224
[TBL] [Abstract][Full Text] [Related]
4. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI).
Ferris S; Schneider L; Farmer M; Kay G; Crook T
Int J Geriatr Psychiatry; 2007 May; 22(5):448-55. PubMed ID: 17117395
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive Outcomes from Memantine: A Pilot, Double-Blind, Placebo-Controlled Trial in Children with Autism Spectrum Disorder.
Soorya LV; Fogg L; Ocampo E; Printen M; Youngkin S; Halpern D; Kolevzon A; Lee S; Grodberg D; Anagnostou E
J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):475-484. PubMed ID: 34543081
[No Abstract] [Full Text] [Related]
7. A pilot open label prospective study of memantine monotherapy in adults with ADHD.
Surman CB; Hammerness PG; Petty C; Spencer T; Doyle R; Napolean S; Chu N; Yorks D; Biederman J
World J Biol Psychiatry; 2013 May; 14(4):291-8. PubMed ID: 22436083
[TBL] [Abstract][Full Text] [Related]
8. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
9. Randomized placebo-controlled crossover trial of memantine in children with epileptic encephalopathy.
Schiller K; Berrahmoune S; Dassi C; Corriveau I; Ayash TA; Osterman B; Poulin C; Shevell MI; Simard-Tremblay E; Sébire G; Myers KA
Brain; 2023 Mar; 146(3):873-879. PubMed ID: 36256600
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.
Aman MG; Findling RL; Hardan AY; Hendren RL; Melmed RD; Kehinde-Nelson O; Hsu HA; Trugman JM; Palmer RH; Graham SM; Gage AT; Perhach JL; Katz E
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):403-412. PubMed ID: 26978327
[TBL] [Abstract][Full Text] [Related]
11. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (1):CD003154. PubMed ID: 12535459
[TBL] [Abstract][Full Text] [Related]
12. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study.
Grant JE; Chamberlain SR; Odlaug BL; Potenza MN; Kim SW
Psychopharmacology (Berl); 2010 Dec; 212(4):603-12. PubMed ID: 20721537
[TBL] [Abstract][Full Text] [Related]
13. Effect of Memantine on Cognitive Performance in Patients Under Electroconvulsive Therapy: A Double-Blind Randomized Clinical Trial.
Alizadeh NS; Maroufi A; Jamshidi M; Hassanzadeh K; Gharibi F; Ghaderi E
Clin Neuropharmacol; 2015; 38(6):236-40. PubMed ID: 26536019
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of adjunctive perampanel on cognition in adolescents with partial seizures.
Piña-Garza JE; Lagae L; Villanueva V; Renfroe JB; Laurenza A; Williams B; Kumar D; Meador KJ
Epilepsy Behav; 2018 Jun; 83():50-58. PubMed ID: 29653338
[TBL] [Abstract][Full Text] [Related]
15. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.
Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R
Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896
[TBL] [Abstract][Full Text] [Related]
17. Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.
Adams J; Alipio-Jocson V; Inoyama K; Bartlett V; Sandhu S; Oso J; Barry JJ; Loring DW; Meador KJ
Epilepsia; 2017 Dec; 58(12):2124-2132. PubMed ID: 28990169
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain--results of a randomized double-blinded, placebo-controlled trial.
Maier C; Dertwinkel R; Mansourian N; Hosbach I; Schwenkreis P; Senne I; Skipka G; Zenz M; Tegenthoff M
Pain; 2003 Jun; 103(3):277-283. PubMed ID: 12791434
[TBL] [Abstract][Full Text] [Related]
19. Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study.
Yang JC; Niu YQ; Simon C; Seritan AL; Chen L; Schneider A; Moghaddam ST; Hagerman PJ; Hagerman RJ; Olichney JM
Neuropsychopharmacology; 2014 Nov; 39(12):2760-8. PubMed ID: 24871547
[TBL] [Abstract][Full Text] [Related]
20. Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies.
Weinreb RN; Liebmann JM; Cioffi GA; Goldberg I; Brandt JD; Johnson CA; Zangwill LM; Schneider S; Badger H; Bejanian M
Ophthalmology; 2018 Dec; 125(12):1874-1885. PubMed ID: 30082073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
